1-Methyl-1H-pyrazole-3-carboxylic acid, 97.0%, 100g

2-[5-Fluoro-1H-benzo[d]imidazol-1-yl]acetic acid, 1g

2-(Piperidin-4-yl)propan-2-ol, 95.0%, 25g

TASELISIB, 95%, 5mg

5-(3-phenoxyphenyl)-1H-1,2,3,4-tetrazole, 98+%, 250mg

5-Bromo-2-methylpyridine N-oxide, 95.0%, 1g

Ethyl 2-(3-bromopyridin-2-yl)acetate, 95.0%, 100mg

4-Fluoro-3-methylthiophenol, 97.0%, 25g

2-Hydroxy-1-naphthoic Acid>98.0%(HPLC)(T)25g

tert-butyl ((1R,3S)-3-acetylcyclopentyl)carbamate compound with tert-butyl ((1S,3R)-3-acetylcyclopentyl)carbamate, 97%, 5g

2-Aminopropanamide hydrochloride, 95.0%, 1g

Na-Boc-Ng-(2,4-dinitrophenyl)-D-2,4-diaminobutyric acid, 98.0%, 250mg

(S)-3-((tert-Butoxycarbonyl)amino)-3-(2,4-dichlorophenyl)propanoic acid, 95.0%, 250mg